Jonathan Ayers is the CEO of IDEXX Laboratories, Inc., a leader in veterinary diagnostics and software solutions. He was born on August 6, 1958, and has a solid educational background with a B.S. in Biology from the University of Maine...

Jonathan Ayers is the CEO of IDEXX Laboratories, Inc., a leader in veterinary diagnostics and software solutions. He was born on August 6, 1958, and has a solid educational background with a B.S. in Biology from the University of Maine and an MBA from Wharton. Jonathan has been with IDEXX since 2005 and has played a key role in its growth and innovation in the veterinary field. Notably, in 2018, he received a total compensation of over $13 million, including a $1.6 million salary and a performance-based bonus that highlighted the success of the company. His strategic decisions led to a significant increase in the company's stock value, which peaked around $644 million in 2021 before stabilizing. He has successfully navigated changes in the market, ensuring the company continues to thrive and adapting to new challenges. Under his leadership, IDEXX has maintained a strong performance focus, balancing short-term achievements with long-term growth goals. Jonathan's long-term approach is reflected in the way he aligns his interests with the company's shareholders, requiring executives to hold shares in the company as part of their compensation requirements.